Donate

industry_news_banner

 

Bioverativ and a UK-based biotech company called Bicycle Therapeutics will work together to try to identify new therapies for hemophilia and also sickle cell disease.  The research will focus on using a new approach – called Bicycles – which the companies hope will lead to a new way to treat the blood disorders.

Read the full press release here: Bicycle, Bioverativ Press Release.

Facebook Comments


Sign up for E-mails, Dateline Magazine, and other ways to stay connected.